Category: 2016

PlatformQ Health Partners with The Obesity Society and Boston University to Launch New Education Website for Clinicians Treating Obesity

Obesity poses one of the biggest public health challenges we face today, resulting in a large disease burden of multiple chronic conditions, and imposing substantial cost to individuals, the healthcare system and society at large. With one-third of the adult US population overweight or obese, health care providers must be prepared to confront this complex disease and identify the optimal management approach for each individual patient. […]

Read More

Lung Cancer still Kills More Americans Than any Other Cancer: What Can Doctors Do?

Lung cancer claims more lives in the U.S. than breast, prostate and colon cancer combined. To help raise awareness, November has been designated Lung Cancer Awareness Month, and OMedLive is joining the cause with three complementary continuing medical education programs for clinicians treating advanced lung cancers. […]

Read More

Heart Failure Summit Addresses New Therapies and Devices for Heart Disease

Clinicians have diagnosed over 30 million people with heart failure in the United States. A syndrome characterized by high mortality, frequent hospitalization and reduced quality of life, heart failure is difficult to treat and about 50% of patients will die from it within five years of a diagnosis.

Improving clinicians’ understanding of heart failure pathophysiology, new medications, surgical interventions and mechanical devices is our best hope in the face of such stark statistics. […]

Read More

Global Genes, PlatformQ Health to Launch RareUniversity.com with Live Coverage from the 2016 RARE Patient Advocacy Summit

Global Genes and PlatformQ Health are pleased to announce that the sold-out 5th Annual RARE Patient Advocacy Summit™ taking place in Huntington Beach, CA September 22 – 23 will be streamed live online at RareUniversity.com, the new rare disease educational site created in partnership between Global Genes and PlatformQ Health. Mindful of the many rare disease community members who can’t attend the Summit in person, RareUniversity will stream four topically aligned breakout tracks each day […]

Read More

PlatformQ Health and Global Genes Partner to Launch RareUniversity, World’s First Shared Rare Disease Clinical & Advocacy Education Platform

Global Genes, a leading global advocacy organization for patients and families fighting rare and genetic diseases, and PlatformQ Health today announced a strategic partnership to develop a first of its kind Educational Platform. The goal of this program is to equip advocates and clinicians with comprehensive tools to help navigate the complex world of rare disease education and advocacy. The Beta launch of the platform will coincide with the RARE Patient Advocacy Summit™ in Huntington Beach, California. Register today. […]

Read More

Understanding SGLT2 Inhibitors, One of the Most Promising Classes of Drugs for Type 2 Diabetes

Humanity has long relied on a mechanism in the kidneys that stores excess glucose to survive periodic famines. But, as industrialized nations began to overcome starvation, an over-abundance of cheap, sugary foods entered our diets. And that same survival mechanism has now become a health risk for millions who struggle with Type 2 diabetes.

[…]

Read More

The Leukemia & Lymphoma Society and PlatformQ Health Partner to Host Inaugural Program on CancerCoachLive, a New Online Patient Education Platform

While so much effort goes into educating the public around cancer prevention, cancer remains largely unpredictable and many thousands each year will be diagnosed. When they are, one critical factor in treatment success is the time it takes to forming a patient’s response plan. As such, PlatformQ Health is launching a new education platform, CancerCoachLive, to empower newly diagnosed cancer patients. […]

Read More

Albert Einstein College of Medicine Supports New CME Website Dedicated to Prostate Cancer

Prostate cancer is the most common and fifth-leading cause of death from cancer in men. In 2014 alone, an estimated 233,000 cases were diagnosed. And, while almost 90% of cases are caught early with prostate-specific antigen (PSA) screening, up to 40% will still develop metastases and worsen despite advancing treatment options. Clinical challenges, such as optimal sequences of therapies and ideal combinations of therapies, can often hinder results. […]

Read More

Update from the AAN Conference: Clinical Insights on Multiple Sclerosis Management from AAN 2016

In the past decade, the MS treatment landscape has advanced dramatically and continues to rapidly evolve. An increasing number of disease-modifying therapies (DMTs) slow disease progression by preventing acute exacerbations and new lesion formation. This year’s annual meeting of the American Academy of Neurology (AAN), to be held in Vancouver, British Columbia, Canada, April 15-21, 2016, is the premier meeting for clinicians and researchers in neurology and a key meeting for those involved […]

Read More

Multiple Myeloma Live, Online Session

Survival and remission rates for multiple myeloma continue to climb as researchers and clinicians apply the latest research to patient treatment plans. With large conferences like ASCO still months away, it’s important to get timely updates on the latest treatment options for Multiple Myeloma.

Shaji Kumar, MD and David Dingli, MD, both Professors of Medicine, Hematology, at the Mayo Clinic in Rochester, Minnesota, will review the latest treatment practices at a one-hour online CME program hosted by OMedLive.com. […]

Read More

CDC and IDCareLive to Host Zika Virus Chat for Medical Clinicians Tomorrow

Zika, already a problem in Puerto Rico and the U.S. Virgin Islands, is expected to reach the mainland U.S. as seasonal temperatures climb and the mosquito responsible for transmission becomes active in states such as Florida, Louisiana, and Texas.

The CDC will host a complimentary, online session, “A CDC Update for Clinicians on Zika Virus Disease.” […]

Read More